Tag Archives: covid

Dr. M’s SPA Newsletter Volume 11 Issue 29 Covid Update #39

Coronavirus Update #39 Quick hits
1) Repeat with new information as an important follow up on MIS-C, multi inflammatory syndrome – c., from 2 weeks ago. Remember that in children, MIS-c is associated with poor intestinal function from a microbiome perspective coupled to genetic weaknesses in immune suppression of chemokine CXCL9 post inflammation. Research from the lab of Dr. Alessio Fasano has shown direct evidence of intestinal permeability in children with multi inflammatory syndrome – c:
The authors found that children, unlike adults, the SARS2 virus decides to take up residence in the intestines and replicate there. The virus can be found in the child’s stool via testing. This is a unique finding to children as the intestine is not known to be a harboring site for the virus in adults. The expert researcher on this paper, Dr. Fasano, has extensive knowledge of the function of the intestinal mucosal lining and the fact that the cells are held together by tight junctions made up of different proteins forming a semi impermeable membrane…….
Read more at https://www.salisburypediatrics.com/patient-education/dr-magryta-s-newsletter
Have a great day,
Dr. M

Dr. M’s SPA Newsletter Volume 11 Issue 25 Covid Update #37

 

What are the latest data trends with COVID and children? What vaccine related issues have arisen? We answer these questions and more!

Quick hits

1) Sequelae following a moderate to severe COVID infection continue to plague medical systems. In a new study in the British Medical Journal, we see a 14% increased risk of developing new onset clinical conditions.

“14% of adults aged ≤65 who were infected with SARS-CoV-2 (27 074 of 193 113) had at least one new type of clinical sequelae that required medical care after the acute phase of the illness, which was 4.95% higher than in the 2020 comparator group. The risk for specific new sequelae attributable to SARS-Cov-2 infection after the acute phase, including chronic respiratory failure, cardiac arrythmia, hypercoagulability, encephalopathy, peripheral neuropathy, amnesia (memory difficulty), diabetes, liver test abnormalities, myocarditis, anxiety, and fatigue, was significantly greater than in the three comparator groups (2020, 2019, and viral lower respiratory tract illness groups).” (Daugherty et. al. 2021)……….

Read More: Link

Enjoy,

Dr. M

Dr. Magryta’s Newsletter Coronavirus Update #36

We must have discourse regarding experimental vaccinations to be a moral society. For this reason, I will take on this controversial topic.
Are we all ok with an emergency use authorization for the COVID19 vaccine for children under age 16 years old? That is a loaded question. In the British Medical Journal we see a piece written by Drs. Pegden, Prasad and Baral this week. They state: “For adults, the benefits of covid-19 vaccination are enormous, while for children they are relatively minor. Rare side effects from adult covid-19 vaccination are unlikely to lead to future vaccine hesitancy whose public health impact could be comparable to the benefits of the adult covid-19 vaccination program itself. But accelerated mass child vaccination under emergency use authorization—perhaps even spurred by school mandates and “vaccine passports”—presents a different balance of risks and benefits. The possibility that rare adverse events could emerge as the more durable public health legacy of an emergency use authorization for child covid-19 vaccines is much greater.” (Pegden et. al. 2021)…….
If you prefer to read the newsletter or see the references, go to https://www.salisburypediatrics.com/patient-education/dr-magryta-s-newsletter/954-volume-11-letter-23-coronavirus-update-36

1 9 10